| Alcohol Studies |
| COGA- the Collaborative Study on the Genetics of Alcoholism | Victor M. Hesselbrock, Ph.D. |
| Contingency Management for Chronic Recidivist Alcohol-Dependent Patients | Nancy M. Petry, Ph.D. |
| Genetic Studies of Alcohol Dependence | Henry R. Kranzler, M.A., M.D. |
| Genetic versus phenotypic markers of relapse risk | Lance O. Bauer, Ph.D. |
| Interactive effects of ART and alcohol among patients living with HIV/AIDS | Lance O. Bauer, Ph.D. |
| Predicting Treatment Outcomes in Adolescent Alcohol Use Disorders | Lance O. Bauer, Ph.D. |
| RISK | Victor M. Hesselbrock, Ph.D. |
| Sertraline Pharmacotherapy for Alcoholism Subtypes | Henry R. Kranzler, M.A., M.D. |
| Subjective and Physiological Effects of Alcohol: Role of Genetic Variation and Adrenal Hormones | Jonathan M. Covault, MD, PhD |
| Subjective and Physiological Responses to Alcohol in Healthy Social Drinkers: Moderating effect of variation in GABRA2 | Jonathan M. Covault, MD, PhD |
| Topiramate Treatment of Problem Drinkers | Henry R. Kranzler, M.A., M.D. |
| Zonisamide versus Placebo in the Treatment of Alcohol Dependence | Albert J. Arias, M.D. |
| |
| Drug Studies |
| Contingency Management for Attendance | Nancy M. Petry, Ph.D. |
| Contingency Management for Marijuana Dependence | Ronald M. Kadden, PhD |
| Contingency Management Reinforcement for Adolescent Cannabis Abuse | Yifrah YK, Kaminer, M.D., M.B.A. |
| Enhanced and Attendance-Based Prize CM in Community Settings | Nancy M. Petry, Ph.D. |
| Genetic Studies of Cocaine Dependence; Genetic Studies of Opiate Dependence | Henry R. Kranzler, M.A., M.D. |
| Group-Based CM for Substance Abuse Treatment | Nancy M. Petry, Ph.D. |
| Lower Cost Contingency Management in a Group Setting | Nancy M. Petry, Ph.D. |
| Vouchers vs. Prizes for Methadone Patients | Nancy M. Petry, Ph.D. |
| |
| Gambling Studies |
| Brief Therapies for Frequent Gambling Substance Abusers | Nancy M. Petry, Ph.D. |
| Cognitive-Behavioral Treatment for Pathological Gambling | Nancy M. Petry, Ph.D. |
| |
| Other Studies |
| A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Sequential Trial of Ziprasidone as Monotherapy for Maj | Andrew Winokur, M.D., Ph.D. |
| A placebo controlled-crossover study of synthetic thyrotropin-releasing hormone in breast and prostate cancer patients | Andrew Winokur, M.D., Ph.D. |
| A randomized long-term safety study of Org 50081 in elderly outpatients with chronic primary insomnia examining the effe | Andrew Winokur, M.D., Ph.D. |
| Cooperative Huntington's Observational Research Trial (COHORT) | Kaloyan S. Tanev, M.D. |
| Maintenance of Response After Open-Label Treatment with Atomoxetine Hydrochloride in Adult Outpatients with ADHD | Jayesh R. Kamath, MD PhD |
| Training Therapists to Administer Contingency Management | Nancy M. Petry, Ph.D. |
